Overview
No overview information available.
Indication
⑴用于胃肠道感染，如痢疾、肠炎、腹膜炎及细菌性腹泻、食物中毒性腹泻等。 ⑵用于成人医院获得性肺炎。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/03/09 | Phase 3 | Terminated | |||
2017/03/28 | Phase 3 | Completed | |||
2015/05/22 | Phase 3 | Completed | |||
2014/06/05 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Colistimethate Sodium for Injection | 国药准字H20213795 | 化学药品 | 注射剂 | 10/19/2021 | |
| Colistimethate Sodium for Injection | 国药准字H20213773 | 化学药品 | 注射剂 | 10/11/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.